{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:48:19Z","timestamp":1792010899300,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032554","name":"Peking University Shenzhen Hospital","doi-asserted-by":"publisher","award":["LCYJ2021005"],"award-info":[{"award-number":["LCYJ2021005"]}],"id":[{"id":"10.13039\/100032554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.acra.2026.09.026","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:54:32Z","timestamp":1791345272000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Asymmetric Complementarity: A Subtype-Specific Strategy via Visual Assessment of DCE-MRI and DWI for Evaluating NAT Efficacy in Breast Cancer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6289-1943","authenticated-orcid":false,"given":"Xiuyun","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianle","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0496-8628","authenticated-orcid":false,"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.09.026_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2026.09.026_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.acra.2026.09.026_bib3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamaoncol.2022.3755","article-title":"Surrogacy of pathologic complete response in trials of neoadjuvant therapy for early breast cancer: critical analysis of strengths, weaknesses, and misinterpretations","volume":"8","author":"Conforti","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acra.2026.09.026_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.2019182947","article-title":"Breast MRI: state of the art","volume":"292","author":"Mann","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.09.026_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-012-2033-5","article-title":"Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer","volume":"135","author":"Wu","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.09.026_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1148\/radiol.2018180273","article-title":"Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial","volume":"289","author":"Partridge","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.09.026_bib7","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.18632\/oncotarget.23195","article-title":"Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: a meta-analysis","volume":"9","author":"Chu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.acra.2026.09.026_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejrad.2013.10.023","article-title":"Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy","volume":"83","author":"Hahn","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2026.09.026_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109931","article-title":"The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: a meta-analysis","volume":"143","author":"Li","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2026.09.026_bib10","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1007\/s00330-025-11640-y","article-title":"Comparison of diffusion-weighted and contrast-enhanced MRI for monitoring response to neoadjuvant therapy in breast cancer","volume":"35","author":"Eom","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.09.026_bib11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00330-019-06510-3","article-title":"Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group","volume":"30","author":"Baltzer","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.09.026_bib12","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-college of American pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2026.09.026_bib13","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.acra.2026.09.026_bib14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1158\/1055-9965.EPI-17-0627","article-title":"Differences in breast cancer survival by molecular subtypes in the United States","volume":"27","author":"Howlader","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.acra.2026.09.026_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.acra.2026.09.026_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41379-020-00714-5","article-title":"Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer","volume":"34","author":"Pastorello","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.acra.2026.09.026_bib17","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.21873\/anticanres.11114","article-title":"Breast cancer subtype influences the accuracy of predicting pathologic response by imaging and clinical breast exam after neoadjuvant chemotherapy","volume":"36","author":"Waldrep","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.acra.2026.09.026_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.acra.2026.09.026_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217094","article-title":"Electroacupuncture facilitates vascular normalization by inhibiting Glyoxalase1 in endothelial cells to attenuate glycolysis and angiogenesis in triple-negative breast cancer","volume":"598","author":"Wan","year":"2024","journal-title":"Cancer Lett"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226007646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226007646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:16:32Z","timestamp":1792008992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226007646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S1076633226007646"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.09.026","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric Complementarity: A Subtype-Specific Strategy via Visual Assessment of DCE-MRI and DWI for Evaluating NAT Efficacy in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}